Qinghai Spring Medicinal Resources Technology Co Ltd (600381) - Net Assets

Latest as of March 2026: CN¥983.66 Million CNY ≈ $143.94 Million USD

Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has net assets worth CN¥983.66 Million CNY (≈ $143.94 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.02 Billion ≈ $149.28 Million USD) and total liabilities (CN¥36.47 Million ≈ $5.34 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 600381 total assets for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥983.66 Million
% of Total Assets 96.43%
Annual Growth Rate 9.16%
5-Year Change -45.09%
10-Year Change -50.11%
Growth Volatility 159.23

Qinghai Spring Medicinal Resources Technology Co Ltd - Net Assets Trend (1998–2025)

This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Qinghai Spring Medicinal Resources Techn to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)

The table below shows the annual net assets of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025. For live valuation and market cap data, see 600381 market cap.

Year Net Assets Change
2025-12-31 CN¥999.61 Million
≈ $146.27 Million		 -3.54%
2024-12-31 CN¥1.04 Billion
≈ $151.64 Million		 -18.23%
2023-12-31 CN¥1.27 Billion
≈ $185.45 Million		 -17.33%
2022-12-31 CN¥1.53 Billion
≈ $224.32 Million		 -15.80%
2021-12-31 CN¥1.82 Billion
≈ $266.39 Million		 -12.02%
2020-12-31 CN¥2.07 Billion
≈ $302.77 Million		 -13.38%
2019-12-31 CN¥2.39 Billion
≈ $349.53 Million		 +0.24%
2018-12-31 CN¥2.38 Billion
≈ $348.68 Million		 +2.71%
2017-12-31 CN¥2.32 Billion
≈ $339.48 Million		 +15.78%
2016-12-31 CN¥2.00 Billion
≈ $293.22 Million		 +13.96%
2015-12-31 CN¥1.76 Billion
≈ $257.31 Million		 +470.08%
2014-12-31 CN¥308.44 Million
≈ $45.13 Million		 +516.46%
2013-12-31 CN¥50.03 Million
≈ $7.32 Million		 -97.68%
2012-12-31 CN¥2.15 Billion
≈ $314.92 Million		 -7.16%
2011-12-31 CN¥2.32 Billion
≈ $339.20 Million		 +2096.55%
2010-12-31 CN¥-116.10 Million
≈ $-16.99 Million		 +34.82%
2009-12-31 CN¥-178.12 Million
≈ $-26.06 Million		 +22.83%
2008-12-31 CN¥-230.81 Million
≈ $-33.78 Million		 +36.31%
2007-12-31 CN¥-362.40 Million
≈ $-53.03 Million		 +15.64%
2006-12-31 CN¥-429.60 Million
≈ $-62.86 Million		 -231.07%
2005-12-31 CN¥327.77 Million
≈ $47.96 Million		 -33.07%
2004-12-31 CN¥489.71 Million
≈ $71.66 Million		 +25.04%
2003-12-31 CN¥391.64 Million
≈ $57.31 Million		 +11.33%
2002-12-31 CN¥351.79 Million
≈ $51.48 Million		 +5.33%
2001-12-31 CN¥333.98 Million
≈ $48.87 Million		 +183.52%
2000-12-31 CN¥117.80 Million
≈ $17.24 Million		 +3.90%
1999-12-31 CN¥113.38 Million
≈ $16.59 Million		 +20.79%
1998-12-31 CN¥93.87 Million
≈ $13.74 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Qinghai Spring Medicinal Resources Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 9816955477.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CN¥97.96 Million 9.84%
Other Components CN¥897.27 Million 90.16%
Total Equity CN¥995.23 Million 100.00%

Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Market Cap

The table below lists competitors of Qinghai Spring Medicinal Resources Technology Co Ltd ranked by their market capitalization.

Company Market Cap
Shenzhen HeKeda Precision Cleaning Equipment Co Ltd
SHE:002816
 $318.71 Million
Metropolis Healthcare Limited
NSE:METROPOLIS
 $318.84 Million
TECHPOINT INC. JDR/1
F:R46
 $318.93 Million
Accent Group Ltd
AU:AX1
 $319.03 Million
Cre8 Direct Ningbo Co Ltd
SHE:300703
 $318.61 Million
JSL S.A
SA:JSLG3
 $318.61 Million
Byggmax Group AB
ST:BMAX
 $318.60 Million
FPT Securities JSC
VN:FTS
 $318.59 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Qinghai Spring Medicinal Resources Technology Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 1,032,551,890 to 995,231,528, a change of -37,320,362 (-3.6%).
  • Net loss of 37,320,363 reduced equity.
  • Other comprehensive income decreased equity by 106,583,374.
  • Other factors increased equity by 106,583,375.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥-37.32 Million -3.75%
Other Comprehensive Income CN¥-106.58 Million -10.71%
Other Changes CN¥106.58 Million +10.71%
Total Change CN¥- -3.61%

Book Value vs Market Value Analysis

This analysis compares Qinghai Spring Medicinal Resources Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.19x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 4.93x to 2.19x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1998-12-31 CN¥0.75 CN¥3.71 x
1999-12-31 CN¥0.88 CN¥3.71 x
2000-12-31 CN¥0.90 CN¥3.71 x
2001-12-31 CN¥2.63 CN¥3.71 x
2002-12-31 CN¥2.72 CN¥3.71 x
2003-12-31 CN¥2.94 CN¥3.71 x
2004-12-31 CN¥3.08 CN¥3.71 x
2005-12-31 CN¥1.78 CN¥3.71 x
2006-12-31 CN¥-3.50 CN¥3.71 x
2007-12-31 CN¥-3.03 CN¥3.71 x
2008-12-31 CN¥-2.16 CN¥3.71 x
2009-12-31 CN¥-1.75 CN¥3.71 x
2010-12-31 CN¥-0.81 CN¥3.71 x
2011-12-31 CN¥7.52 CN¥3.71 x
2012-12-31 CN¥50.25 CN¥3.71 x
2013-12-31 CN¥-0.16 CN¥3.71 x
2014-12-31 CN¥0.50 CN¥3.71 x
2015-12-31 CN¥2.75 CN¥3.71 x
2016-12-31 CN¥3.18 CN¥3.71 x
2017-12-31 CN¥3.95 CN¥3.71 x
2018-12-31 CN¥4.17 CN¥3.71 x
2019-12-31 CN¥4.11 CN¥3.71 x
2020-12-31 CN¥3.50 CN¥3.71 x
2021-12-31 CN¥3.08 CN¥3.71 x
2022-12-31 CN¥2.61 CN¥3.71 x
2023-12-31 CN¥2.17 CN¥3.71 x
2024-12-31 CN¥1.77 CN¥3.71 x
2025-12-31 CN¥1.70 CN¥3.71 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Qinghai Spring Medicinal Resources Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -3.75%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -10.87%
  • • Asset Turnover: 0.33x
  • • Equity Multiplier: 1.05x
  • Recent ROE (-3.75%) is below the historical average (4.33%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1998 10.36% 7.49% 0.61x 2.27x CN¥337.40K
1999 14.17% 16.70% 0.38x 2.21x CN¥4.56 Million
2000 15.65% 16.92% 0.34x 2.71x CN¥6.37 Million
2001 5.93% 13.62% 0.24x 1.82x CN¥-13.35 Million
2002 6.09% 6.81% 0.39x 2.26x CN¥-13.24 Million
2003 7.52% 6.22% 0.38x 3.22x CN¥-9.10 Million
2004 4.91% 1.90% 0.58x 4.46x CN¥-19.55 Million
2005 -72.08% -27.40% 0.43x 6.17x CN¥-182.59 Million
2006 0.00% -646.14% 0.20x 0.00x CN¥-514.68 Million
2007 0.00% 528.31% 0.03x 0.00x CN¥89.36 Million
2008 0.00% 287.43% 0.11x 0.00x CN¥144.01 Million
2009 0.00% 97.04% 0.15x 0.00x CN¥73.20 Million
2010 0.00% 87.31% 0.07x 0.00x CN¥68.54 Million
2011 4.80% 38.78% 0.06x 2.04x CN¥-100.26 Million
2012 16.37% 22.54% 0.32x 2.25x CN¥114.60 Million
2013 0.00% 15.74% 1.44x 0.00x CN¥340.57 Million
2014 150.44% 17.70% 1.44x 5.91x CN¥340.94 Million
2015 20.38% 25.51% 0.66x 1.20x CN¥182.10 Million
2016 12.25% 34.59% 0.32x 1.11x CN¥44.99 Million
2017 13.41% 65.92% 0.19x 1.05x CN¥79.01 Million
2018 2.88% 20.55% 0.14x 1.02x CN¥-169.54 Million
2019 0.24% 2.48% 0.10x 1.01x CN¥-233.06 Million
2020 -15.44% -257.14% 0.06x 1.07x CN¥-526.45 Million
2021 -13.66% -194.59% 0.07x 1.02x CN¥-430.66 Million
2022 -18.76% -179.52% 0.10x 1.02x CN¥-440.84 Million
2023 -21.17% -125.24% 0.16x 1.07x CN¥-394.37 Million
2024 -19.25% -73.55% 0.23x 1.13x CN¥-302.02 Million
2025 -3.75% -10.87% 0.33x 1.05x CN¥-136.84 Million

Industry Comparison

This section compares Qinghai Spring Medicinal Resources Technology Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $3,747,874,691
  • Average return on equity (ROE) among peers: 10.15%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) CN¥983.66 Million 10.36% 0.04x $318.71 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $1.44 Billion -15.24% 1.79x $608.33 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.22 Billion 5.35% 1.27x $361.75 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $2.46 Billion 15.95% 0.27x $4.81 Billion
Livzon Pharmaceutical Group Inc (000513) $14.77 Billion 13.23% 0.70x $2.66 Billion
Wedge Industrial Co Ltd (000534) $760.85 Million 18.95% 0.28x $1.86 Billion
Yunnan Baiyao Group Co Ltd (000538) $279.81 Million 10.28% 0.26x $13.37 Billion
Hainan Haiyao Co Ltd (000566) $5.08 Billion 1.71% 1.08x $899.87 Million
Tus Pharmaceutical Group Co Ltd (000590) $322.78 Million 6.31% 0.77x $274.38 Million
Northeast Pharmaceutical Group Co Ltd (000597) $2.05 Billion 23.18% 1.96x $977.31 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $9.09 Billion 21.79% 0.11x $3.23 Billion

About Qinghai Spring Medicinal Resources Technology Co Ltd

SHG:600381 China Drug Manufacturers - Specialty & Generic
Market Cap
$318.71 Million
CN¥2.18 Billion CNY
Market Cap Rank
#14334 Global
#4165 in China
Share Price
CN¥3.71
Change (1 day)
-1.85%
52-Week Range
CN¥2.61 - CN¥5.70
All Time High
CN¥24.91
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health products in China. It operates through two segments, Wine and Beverage Fast-Moving Consumer Goods and Big Health. The Wine and Beverage Fast-Moving Consumer Goods segment focuses on the sales of alcoholic beverages, including the Tinghua series wines. The Big Health segment engages in the… Read more